ATE131828T1 - Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen - Google Patents

Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen

Info

Publication number
ATE131828T1
ATE131828T1 AT89907183T AT89907183T ATE131828T1 AT E131828 T1 ATE131828 T1 AT E131828T1 AT 89907183 T AT89907183 T AT 89907183T AT 89907183 T AT89907183 T AT 89907183T AT E131828 T1 ATE131828 T1 AT E131828T1
Authority
AT
Austria
Prior art keywords
peptides
properties against
protective properties
sensitive cells
pathogenic virus
Prior art date
Application number
AT89907183T
Other languages
English (en)
Inventor
Jean-Michel Claverie
Lydie Bougeleret
Philippe Kourilsky
Pierre Langlade-Demoyen
Ada Chalufour-Prochnicka
Gilles Dadaglio
Fredj Tekaia
Fernando Plata
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE131828T1 publication Critical patent/ATE131828T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89907183T 1988-06-06 1989-06-06 Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen ATE131828T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8807504A FR2632310B1 (fr) 1988-06-06 1988-06-06 Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles

Publications (1)

Publication Number Publication Date
ATE131828T1 true ATE131828T1 (de) 1996-01-15

Family

ID=9366976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89907183T ATE131828T1 (de) 1988-06-06 1989-06-06 Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen

Country Status (5)

Country Link
EP (1) EP0375767B1 (de)
AT (1) ATE131828T1 (de)
DE (1) DE68925191D1 (de)
FR (1) FR2632310B1 (de)
WO (1) WO1989012066A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677654B1 (fr) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387914B1 (de) * 1984-10-18 1993-08-04 Institut Pasteur Hüllenantigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
DK3687A (da) * 1986-01-06 1987-07-07 Hoffmann La Roche Polypeptider og fremgangsmaade til fremstilling deraf
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
FR2600335B1 (fr) * 1986-06-19 1988-09-30 Pasteur Institut Procede d'analyse des sequences peptidiques immunogenes portant un epitope caracteristique d'une proteine etrangere a l'organisme d'un hote vivant, en vue de la production de vaccins
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections

Also Published As

Publication number Publication date
DE68925191D1 (de) 1996-02-01
FR2632310A1 (fr) 1989-12-08
FR2632310B1 (fr) 1992-04-10
WO1989012066A1 (fr) 1989-12-14
EP0375767A1 (de) 1990-07-04
EP0375767B1 (de) 1995-12-20

Similar Documents

Publication Publication Date Title
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
ATE520783T1 (de) Lentivirale vektoren
EA199901031A1 (ru) Производные бензимидазола
ES2061500T5 (es) Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
GB2255777B (en) Indicator cells and recombinant retroviruses for use in the detection of gene sequences
CA2164818A1 (en) Tandem synthetic hiv-1 peptides
ATE174222T1 (de) Blockierung der anlagerung von keimen an menschliche zellen
DE69322872T2 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
ATE164853T1 (de) Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
KR100725637B1 (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein
DE68910577D1 (de) Mittel gegen den AIDS-Virus.
ES2061495T3 (es) Peptidos relacionados con el virus htlv-iii, anticuerpos para los peptidos, vacunas, inmunizacion activa y pasiva contra el virus del sida y prueba diagnostica para la deteccion serologica del virus del sida.
DE68925191D1 (de) Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen
DE69534361D1 (de) Therapeutische Quassinoid-Zubereitungen mit antineoplastischer, antiviraler und herbistatischer Wirkung
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ATE103980T1 (de) Das f-protein vom aids-virus enthaltender impfstoff.
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
ES2062502T3 (es) Una proteina de factor i pura y un procedimiento para obtener dicha proteina.
ES2145055T3 (es) Peptidos, sus analogos y mezclas para detectar y producir anticuerpos de las proteinas e1 y e2 del virus de la rubeola.
ATE93141T1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
SU1702657A1 (ru) Пептид, обладающий защитным действием против вируса ящура штамма a
DE69009066D1 (de) SIV cpz-ant Retrovirus und seine Anwendungen.
SU717773A1 (ru) Микропрограммный процессор
HUP9904262A2 (hu) Fehérjék alkalmazása retrovírus elleni szerként

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties